Response to ritlecitinib with or without narrow-band ultraviolet B add-on therapy in patients with active nonsegmental vitiligo: Results from a phase 2b extension study. - Yamaguchi Y; Peeva E; Adiri R; Ghosh P; Napatalung L; Hamzavi I; Pandya AG; Shore RN; Ezzedine K; Guttman-Yassky E (Journal of the American Academy of Dermatology, 2025)